
Ides of March (3.15.2024)
Rheumnow Podcast
00:00
Exploration of IL-17 Inhibitors and Lupus Management in Various Scenarios
This chapter delves into adverse events associated with IL-17 inhibitors, discusses discontinuation rates, ISRs, and IBD occurrences, while also examining studies on lupus related to remission rates in pregnant patients, lupus-thrombocytopenia association, and antiphospholipid antibodies impact. Moreover, it highlights the importance of appropriate lupus management in patients on hemodialysis and cautions against halting lupus therapy for faster hemodialysis access.
Transcript
Play full episode